10/24/2018 08:45 AM
- 10/24/2018 09:35 AM
Are medical device companies ready for another round of healthcare disruption? How are they preparing for the digitization of medicine, for the advent of artificial intelligence, for accountable care models? Experts on the panel will answer these questions and envision the overall role of medtech in a new value-based system.
Moderator: Wael Barsoum, MD, President & CEO, Cleveland Clinic Florida
AJ Abdallat, CEO, Beyond Limits
Sri Chalikonda, MD, Chief of Clinical Operations and Strategic Initiatives, Allegheny Health Network
Arthur Hanson, MD, CEO, Palm Beach Accountable Care Organization
Tim Scannell, President & COO, Stryker
10/24/2018 09:35 AM
- 10/24/2018 10:15 AM
As the typical players – payors, providers, corporations, and government agencies – are tangled in a web of competing incentives, there are some new players starting to make their move. This panel will feature some of the unlikely companies and their non-traditional solutions that are intending to do more than just turn heads.
Moderator: Dawn Owens, President, TripleTree
Olaoluwa Fayanju, MD, Senior Medical Director, Oakstreet Health
Emmanuel Fombu, MD, Medical Director & CV Digital Medicine Lead, Novartis
Dennis Weaver, MD, Chief Clinical Officer, Oscar
10/24/2018 10:45 AM
- 10/24/2018 11:45 AM
To many, the human face defines personhood. When it is devastated beyond the reach of conventional plastic or restorative surgery, a patient may lament both the loss of their appearance and simple functional abilities such as smiling, talking, eating, or breathing on their own. In these rare instances, a face transplant may be the only solution that can sufficiently restore the patient’s quality of life and function, On this panel, you will hear from members of the multi-disciplinary team who performed the first total face transplant on 21-year-old Katie Stubblefield, the youngest face transplant patient in the US.
Moderator: Frank Papay, MD, Chair, Dermatology & Plastic Surgery, Cleveland Clinic
Kathy Coffman, MD, Staff, Center for Behavioral Health, Cleveland Clinic
Bijan Eghtesad, MD, Staff, Transplantation Center, Cleveland Clinic
Brian Gastman, MD, Dermatology & Plastic Surgery Institute, Cleveland Clinic
Eric Kodish, MD, Staff, Center for Bioethics, Cleveland Clinic
Alan Lichtin, MD, Chair, Institutional Review Board, Cleveland Clinic
Heather Mekesa, Chief Hospital & Clinical Services Officer, Lifebanc
Debra Priebe, RN, BSN, CCTC, Assistant Nurse Manager, Lead Transplant Coordinator, Cleveland Clinic
Maria Siemionow, MD, PhD, DSc, Professor of Orthopaedics, Director of Microsurgery Research, University of Illinois at Chicago
Eileen Sheil, Executive Director, Corporate Communications, Cleveland Clinic
Karl West, Director, Medical Device Solution, Cleveland Clinic
10/24/2018 11:45 AM
- 10/24/2018 12:45 PM
Cleveland Clinic’s Top 10 list of breakthrough technologies for the coming year has become an international sensation. Join us again as Dr. Mike Roizen and a panel of ten Clinic leaders roll out these much anticipated selections.
Moderator: Mike Roizen, MD, Chief Wellness Officer
Mark Bain, MD, Neurological Institute
Hetty Carraway, MD, Taussig Cancer Institute
Tom Gildea, MD, Respiratory Institute
Shazam Hussain, MD, Director, Cerebrovascular Center
Jennifer Hockings PharmD, PhD, Genomic Medicine Institute
Samir Kapadia, MD, Heart & Vascular Institute
Jihad Kaouk, MD, Director, Center for Robotic & Image Guided Surgery
Ed Marx, Chief Information Officer
Neil Mehta, MD, Education Institute
Olga Stenina-Adognravi, PhD, Lerner Research Institute
North Olmsted High School biomedicine students participated in the Cleveland Clinic's Judging Innovation program Oct. 22 at the Huntington Convention Center of Cleveland.
The opioid crisis has been declared a public health emergency. Today, chronic pain is the leading cause of opioid prescription. Though several clinically validated alternative therapies for chronic pain exist, none have curtailed the crisis. Now, innovation and potential for hope comes by way of pharmacogenomic testing, which uses a patient’s genetic makeup to predict an individual’s metabolism of drugs, including some opiate-based drugs.
A big healthcare system well known for its annual forecast of emerging trends that will significantly impact healthcare in the next year has named artificial intelligence as one of the those trends.
The expanded window for thrombectomy in acute stroke care ranked No. 3 on Cleveland Clinic’s top 10 medical innovations for 2019—one of several developments on the list with implications for cardiovascular treatment.
98point6 is on a mission to make primary care more efficient with the use of artificial intelligence. The Seattle, WA-based company said it raised $50 million in a series C round, bringing the total amount raised to $86.1 since the company’s inception in 2015.
Epic CEO Judy Faulkner had a message for women working in healthcare and technology. “Be a builder,” Faulkner said at the annual Cleveland Clinic Medical Innovations Summit.
Cleveland Clinic released its list of top 10 medical innovations that could disrupt healthcare in 2019. Topping the list is alternative pain therapy to combat the nationwide opioid crisis — in particular, pharmacogenomic testing, which uses a patient's genetic makeup to predict how they metabolize drugs.
YouScript has been named as the clinical track winner in the Cleveland Clinic Medical Innovation Startup Showcase, honoring companies best positioned to disrupt healthcare and make change. Cleveland Clinic, JumpStart, HIMSS, HealthXL and Plug and Play voted on 5-minute live pitches to kick off the 2018 Medical Innovation Summit in Cleveland, OH on October 22, 2018.
Alternative pain management therapies and the increased use of artificial intelligence are among the top 10 trends and innovations in medicine, according to physicians and researchers at the Cleveland Clinic.
Cleveland Clinic has unveiled its annual list of 10 medical innovations it expects will enhance healing and change health care next year, including alternative therapies for pain, expanded window to treat stroke patients and the use of artificial intelligence in health care.